These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1638582

  • 21. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?
    Feig DS, Briggs GG, Koren G.
    Ann Pharmacother; 2007 Jul; 41(7):1174-80. PubMed ID: 17535842
    [Abstract] [Full Text] [Related]

  • 22. Ocular effects of second generation oral hypoglycemic agents.
    Lightman JM, Townsend JC, Selvin GJ.
    J Am Optom Assoc; 1989 Nov; 60(11):849-53. PubMed ID: 2514224
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics of gliquidone, glibenclamide, gliclazide and glipizide in middle-aged and aged subjects.
    Courtois P, Sener A, Herbaut C, Turc A, Malaisse WJ.
    Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):211-22. PubMed ID: 10461687
    [Abstract] [Full Text] [Related]

  • 24. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
    Borisova AM, Taneva T, Koev D, Georgieva R.
    Vutr Boles; 1988 Feb; 27(2):85-9. PubMed ID: 3137730
    [Abstract] [Full Text] [Related]

  • 25. Combination agents for diabetes.
    Samuel J, Rochester CD.
    Adv Nurse Pract; 2003 Jun; 11(6):22-4. PubMed ID: 12807051
    [No Abstract] [Full Text] [Related]

  • 26. Multicenter comparison of glyburide and glipizide in the treatment of non-insulin-dependent diabetes mellitus.
    Kilo C.
    Clin Ther; 1988 Jun; 10(3):294-302. PubMed ID: 3152586
    [Abstract] [Full Text] [Related]

  • 27. Effect of some penetration enhancers on the permeation of glibenclamide and glipizide through mouse skin.
    Mutalik S, Udupa N.
    Pharmazie; 2003 Dec; 58(12):891-4. PubMed ID: 14703968
    [Abstract] [Full Text] [Related]

  • 28. Residual effects of a short-term intensified insulin therapy in type 2 diabetic patients with oral drug failure.
    Féry F, Desir D, Mockel J.
    Diabete Metab; 1991 Dec; 17(6):525-9. PubMed ID: 1809598
    [Abstract] [Full Text] [Related]

  • 29. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J, Vandenberg M, Grunberger G.
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [Abstract] [Full Text] [Related]

  • 30. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P.
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [Abstract] [Full Text] [Related]

  • 31. [Glipizide in the treatment of non-insulin-dependent diabetes mellitus].
    Luis Iriarte J.
    Rev Clin Esp; 1989 Jun; 185(1):24-32. PubMed ID: 2772334
    [Abstract] [Full Text] [Related]

  • 32. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS.
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [Abstract] [Full Text] [Related]

  • 33. Transfer of glyburide and glipizide into breast milk.
    Feig DS, Briggs GG, Kraemer JM, Ambrose PJ, Moskovitz DN, Nageotte M, Donat DJ, Padilla G, Wan S, Klein J, Koren G.
    Diabetes Care; 2005 Aug; 28(8):1851-5. PubMed ID: 16043722
    [Abstract] [Full Text] [Related]

  • 34. Oral sulfonylureas for the treatment of type II diabetes: an update.
    Shank WA, Morrison AD.
    South Med J; 1986 Mar; 79(3):337-43. PubMed ID: 3082015
    [Abstract] [Full Text] [Related]

  • 35. Crossover comparison of maximum dose glyburide and glipizide.
    Simcic KJ, McDermott MT, White JC, Kidd GS.
    South Med J; 1991 Jun; 84(6):743-6. PubMed ID: 1905060
    [Abstract] [Full Text] [Related]

  • 36. Glyburide versus glipizide in the treatment of patients with non-insulin-dependent diabetes mellitus.
    Kilo C, Meenan A, Bloomgarden Z.
    Clin Ther; 1992 Jun; 14(6):801-12. PubMed ID: 1286487
    [Abstract] [Full Text] [Related]

  • 37. Transdermal delivery of glibenclamide and glipizide: in vitro permeation studies through mouse skin.
    Mutalik S, Udupa N.
    Pharmazie; 2002 Dec; 57(12):838-41. PubMed ID: 12561248
    [Abstract] [Full Text] [Related]

  • 38. Sentinel Modular Program for Propensity Score-Matched Cohort Analyses: Application to Glyburide, Glipizide, and Serious Hypoglycemia.
    Zhou M, Wang SV, Leonard CE, Gagne JJ, Fuller C, Hampp C, Archdeacon P, Toh S, Iyer A, Woodworth TS, Cavagnaro E, Panozzo CA, Axtman S, Carnahan RM, Chrischilles EA, Hennessy S.
    Epidemiology; 2017 Nov; 28(6):838-846. PubMed ID: 28682851
    [Abstract] [Full Text] [Related]

  • 39. Hypoglycemia from glipizide and glyburide.
    Gambassi G, Carbonin P, Bernabei R.
    JAMA; 1998 May 13; 279(18):1442-3. PubMed ID: 9600474
    [No Abstract] [Full Text] [Related]

  • 40. Glipizide pharmacokinetics: effects of age, diabetes, and multiple dosing.
    Kradjan WA, Kobayashi KA, Bauer LA, Horn JR, Opheim KE, Wood FJ.
    J Clin Pharmacol; 1989 Dec 13; 29(12):1121-7. PubMed ID: 2693502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.